No Data
Chiome Bioscience: Confirmatory letter.
Chiome Bioscience: Corrected Financial Report - 20th Term (2023/01/01 - 2023/12/31)
GMO-FG, Kringle, and others
<166A> Taski HD increased dividends, with the current year-end dividend per share at 16.00 yen, up from 15.00 yen. <2342> Trans GG revises its performance forecast, with the current operating profit estimate at a loss of 0.11 billion yen, down from 0.35 billion yen. Dividend forecast revised, with the year-end dividend suspended. <4051> GMO-FG increased dividends, with the previous period's year-end dividend per share at 62.00 yen, up from 52.00 yen. <4168> Yapri revises its performance forecast, with the current operating profit estimate at 0.55 billion yen, up from 0.5 billion yen. <4583> Kaiom revises its performance forecast, with the current revenue estimate at 6.00.
Chiome Bioscience Revises Forecast Amid Financial Challenges
Chiome Bioscience: Financial results supplementary materials 3rd quarter of the fiscal year ending 2024/12
Chiome Bioscience: Notice regarding the recording of non-operating expenses and revisions to earnings forecasts
No Data
No Data